Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share
-
Shares outstanding
-
40,291,821
-
Total 13F shares
-
6,298,127
-
Share change
-
+1,670,756
-
Total reported value
-
$27,536,000
-
Price per share
-
$4.45
-
Number of holders
-
12
-
Value change
-
+$7,434,933
-
Number of buys
-
3
-
Number of sells
-
3
Institutional Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) as of Q2 2022
As of 30 Jun 2022 Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) had 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,298,127 shares of stock of the company.
Largest 10 holders included Alphabet Inc., SC CHINA HOLDING Ltd, M&G INVESTMENT MANAGEMENT LTD, DC Funds, LP, Liontrust Investment Partners LLP, BlueCrest Capital Management Ltd, Tudor Investment Corp Et Al, Johns Hopkins University, MILLENNIUM MANAGEMENT LLC, and Ipswich Investment Management Co., Inc..
This table shows 12 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.